Volpara Health Technologies (ASX: VHT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Volpara Health Technologies Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Volpara Health Technologies (ASX: VHT)
Latest News
Share Market News
Volpara delivers more strong growth in Q1 of FY 2020
Share Gainers
ALL ORDINARIES finishes lower Friday: 8 shares you missed
Defensive Shares
2 ASX healthcare shares for any portfolio
Share Gainers
Why the Volpara share price charged higher today
Speculative
3 small cap ASX healthcare shares which could have big futures
Growth Shares
Bring your portfolio to life with CSL and these ASX healthcare shares
Share Gainers
ALL ORDINARIES finishes lower Monday: 8 shares you missed
Growth Shares
Why you should consider ASX small cap investing
Speculative
3 exciting small cap ASX healthcare shares to watch in FY20
Share Gainers
Volpara share price charges higher on ScreenPoint distribution agreement news
Speculative
3 exciting ASX small cap tech shares to watch in FY20
⏸️ Best ASX Shares
Top ASX stock picks for July
Frequently Asked Questions
-
No, the ASX healthcare share has not yet paid any dividends.
-
Volpara listed on 27 April 2016.
VHT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Volpara Health Technologies
Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.
Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.
Volpara Health Technologies Ltd (ASX: VHT) was removed from the ASX Official List on 22 May 2024.
